Go outside to get some fresh air
2013 Jul;169 Suppl 2(0 2):1-8
Emerging evidence has identified additional pharmacological benefits of GIPR agonism beyond its well-established physiological incretin effect, such as reduction of food intake directly via CNS signaling, promotion of lipolysis in the fasted state, and improvement of GLP-1R agonist tolerability
This article does not claim that compounded GLP-1 medications are generic versions of, equivalent to, or substitutable for Ozempic, Wegovy, Mounjaro, or Zepbound
Libertis extensive experience and see examples of his work products view his LinkedIn profile here: Legal Disclaimer: The information contained in this article is provided for informational purposes only and should not be construed as medical or legal advice on any subject matter
Data Animal Data When galcanezumab-gnlm was administered to female rats by subcutaneous injection in two studies (0, 30, or 100 mg/kg